Malcolm Weir
Vorstandsvorsitzender bei Heptares Therapeutics Ltd.
Ursprung des Netzwerks ersten Grades von Malcolm Weir
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.
21
| Subsidiary | Pharmaceuticals: Major | 21 |
The Biochemical Society
 The Biochemical Society Miscellaneous Commercial ServicesCommercial Services The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.
15
| Non-Profit Organization | Miscellaneous Commercial Services | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Malcolm Weir
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| PORTAGE BIOTECH INC. | Biotechnology | Chief Executive Officer | |
Tal Medical, Inc.
 Tal Medical, Inc. Medical SpecialtiesHealth Technology Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Leeds | College/University | Doctorate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apax Partners Holdings Ltd.
 Apax Partners Holdings Ltd. Financial ConglomeratesFinance Apax Partners Holdings Ltd. provides investment services. The firm focuses in the area of media, retail, health care, financial, and telecommunication sectors. The company was founded on February 6, 1991 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Corporate Officer/Principal | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
| The University of Nottingham | College/University | Doctorate Degree | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer | |
Academy of Medical Sciences
 Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Takeda Cambridge Ltd.
 Takeda Cambridge Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Cambridge Ltd. is a company that develops and manufactures pharmaceutical products. The company is based in Cambridge, UK and was founded in 1998. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Private Equity Analyst | |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor | |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MRC Laboratory of Molecular Biology
 MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services MRC Laboratory of Molecular Biology provides biological research and development services. it also offers methods for determining the three-dimensional structures of proteins and other macromolecules, the sequencing of DNA and the development of monoclonal antibodies. The company was founded by Max Ferdinand Perutz in 1962 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Parke-Davis Pharmaceutical Research, Inc. | Director/Board Member | ||
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Michigan Medical School | College/University | Corporate Officer/Principal | |
| Verity BioConsulting LLC | Chief Executive Officer | ||
| Healthcare Executive Group | Director of Finance/CFO | ||
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member | |
| CREO MEDICAL GROUP PLC | Medical Specialties | Director/Board Member | |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science. | Investment Managers | Director of Finance/CFO | |
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Biotechnology | Director/Board Member | |
Portland Press Ltd.
 Portland Press Ltd. Commercial Printing/FormsCommercial Services Part of The Biochemical Society, Portland Press Ltd. is a British company that engages in publication and distribution of scientific journals and books. The company is based in London, UK. The company was founded in 1990. The CEO is Catherine Frances Baillie. | Commercial Printing/Forms | Chairman Director/Board Member | |
Syncona Discovery Ltd.
 Syncona Discovery Ltd. Financial ConglomeratesFinance Part of Syncona Ltd., Syncona Discovery Ltd. is a British company that provides investment services. The company is based in London, UK. Syncona Discovery was founded in 2013. | Financial Conglomerates | Director/Board Member | |
Myricx Pharma Ltd.
 Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Science Creates Ventures
 Science Creates Ventures Investment ManagersFinance Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom. | Investment Managers | Consultant / Advisor | |
| Apterna Ltd. | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 27 |
| Vereinigte Staaten | 17 |
| Irland | 3 |
| Japan | 3 |
| Belgien | 2 |
Sektoral
| Health Technology | 28 |
| Commercial Services | 8 |
| Finance | 8 |
| Consumer Services | 6 |
Operativ
| Director/Board Member | 150 |
| Corporate Officer/Principal | 64 |
| Chairman | 32 |
| Independent Dir/Board Member | 28 |
| Chief Tech/Sci/R&D Officer | 19 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Steinmetz | 35 |
| Declan Doogan | 28 |
| John Bradshaw | 27 |
| John Berriman | 24 |
| Atul Pande | 20 |
| Roger Perlmutter | 19 |
| Peter Bains | 19 |
| Kenneth Buechler | 16 |
| Daniel S. Grau | 13 |
| Fiona Hamilton Marshall | 12 |
| Roberto Solari | 10 |
| Barry Kenny | 8 |
| Manos Topoglidis | 7 |
| Kong Hung Lee | 7 |
| Miles Congreve | 5 |
- Börse
- Insiders
- Malcolm Weir
- Unternehmensverbindungen
